181 related articles for article (PubMed ID: 11713770)
1. Technology evaluation: AAV-CFTR vector, targeted genetics.
Tebbutt SJ
Curr Opin Mol Ther; 1999 Aug; 1(4):524-9. PubMed ID: 11713770
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for cystic fibrosis.
Flotte TR
Curr Opin Mol Ther; 1999 Aug; 1(4):510-6. PubMed ID: 11713767
[TBL] [Abstract][Full Text] [Related]
3. A sensitive, real-time, RNA-specific PCR method for the detection of recombinant AAV-CFTR vector expression.
Gerard CJ; Dell'Aringa J; Hale KA; Klump WM
Gene Ther; 2003 Sep; 10(20):1744-53. PubMed ID: 12939641
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
Flotte TR
Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
[TBL] [Abstract][Full Text] [Related]
5. Efficient CFTR expression from AAV vectors packaged with promoters--the second generation.
Wang D; Fischer H; Zhang L; Fan P; Ding RX; Dong J
Gene Ther; 1999 Apr; 6(4):667-75. PubMed ID: 10476227
[TBL] [Abstract][Full Text] [Related]
6. Technology evaluation: cystic fibrosis therapy, Genzyme.
Cockett MI
Curr Opin Mol Ther; 1999 Apr; 1(2):279-83. PubMed ID: 11715952
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.
Kearns WG; Afione SA; Fulmer SB; Pang MC; Erikson D; Egan M; Landrum MJ; Flotte TR; Cutting GR
Gene Ther; 1996 Sep; 3(9):748-55. PubMed ID: 8875221
[TBL] [Abstract][Full Text] [Related]
8. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
[TBL] [Abstract][Full Text] [Related]
9. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of exposure and health care worker response to nebulized administration of tgAAVCF to patients with cystic fibrosis.
Croteau GA; Martin DB; Camp J; Yost M; Conrad C; Zeitlin PL; Heald AE
Ann Occup Hyg; 2004 Nov; 48(8):673-81. PubMed ID: 15507460
[TBL] [Abstract][Full Text] [Related]
11. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.
Wagner JA; Nepomuceno IB; Messner AH; Moran ML; Batson EP; Dimiceli S; Brown BW; Desch JK; Norbash AM; Conrad CK; Guggino WB; Flotte TR; Wine JJ; Carter BJ; Reynolds TC; Moss RB; Gardner P
Hum Gene Ther; 2002 Jul; 13(11):1349-59. PubMed ID: 12162817
[TBL] [Abstract][Full Text] [Related]
12. CFTR gene transduction in neonatal rabbits using an adeno-associated virus (AAV) vector.
Rubenstein RC; McVeigh U; Flotte TR; Guggino WB; Zeitlin PL
Gene Ther; 1997 May; 4(5):384-92. PubMed ID: 9274714
[TBL] [Abstract][Full Text] [Related]
13. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
[TBL] [Abstract][Full Text] [Related]
14. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
Conrad CK; Allen SS; Afione SA; Reynolds TC; Beck SE; Fee-Maki M; Barrazza-Ortiz X; Adams R; Askin FB; Carter BJ; Guggino WB; Flotte TR
Gene Ther; 1996 Aug; 3(8):658-68. PubMed ID: 8854091
[TBL] [Abstract][Full Text] [Related]
15. Current development of adeno-associated viral vectors.
Romano G
Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
[TBL] [Abstract][Full Text] [Related]
16. [Post-translational ligation and function of dual-vector transferred split CFTR gene].
Zhu FX; Liu ZL; Qu HG; Chi XY
Yao Xue Xue Bao; 2010 Jan; 45(1):60-5. PubMed ID: 21351451
[TBL] [Abstract][Full Text] [Related]
17. Update on gene therapy for cystic fibrosis.
Griesenbach U; Geddes DM; Alton EW
Curr Opin Mol Ther; 2003 Oct; 5(5):489-94. PubMed ID: 14601517
[TBL] [Abstract][Full Text] [Related]
18. A Novel AAV-mediated Gene Delivery System Corrects CFTR Function in Pigs.
Cooney AL; Thornell IM; Singh BK; Shah VS; Stoltz DA; McCray PB; Zabner J; Sinn PL
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):747-754. PubMed ID: 31184507
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for cystic fibrosis: a clinical perspective.
Alton EW; Geddes DM
Gene Ther; 1995 Mar; 2(2):88-95. PubMed ID: 7536619
[TBL] [Abstract][Full Text] [Related]
20. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
Zhang LN; Karp P; Gerard CJ; Pastor E; Laux D; Munson K; Yan Z; Liu X; Godwin S; Thomas CP; Zabner J; Shi H; Caldwell CW; Peluso R; Carter B; Engelhardt JF
Mol Ther; 2004 Dec; 10(6):990-1002. PubMed ID: 15564131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
